LGALS1 and myeloproliferative disorder: A progressive and highly significant increase in galectin-1 expression was observed with progression of MPN to fibrosis (monotonic trend from controls to PV/ET to myelofibrosis, P < 0.0055, Fig. 7D), with a 3.4-fold increase in myelofibrosis vs. controls.